Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Identifieur interne : 000192 ( France/Analysis ); précédent : 000191; suivant : 000193Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Auteurs : T. A. Zesiewicz [États-Unis] ; K. L. Sullivan [États-Unis] ; I. Arnulf [France] ; K. R. Chaudhuri [Royaume-Uni] ; J. C. Morgan [États-Unis] ; G. S. Gronseth [États-Unis] ; J. Miyasaki [Canada] ; D. J. Iverson [États-Unis] ; W. J. Weiner [États-Unis]Source :
- Neurology [ 0028-3878 ] ; 2010.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Neurologie.
English descriptors
Abstract
Objective: Nonmotor symptoms (sleep dysfunction, sensory symptoms, autonomic dysfunction, mood disorders, and cognitive abnormalities) in Parkinson disease (PD) are a major cause of morbidity, yet are often underrecognized. This evidence-based practice parameter evaluates treatment options for the nonmotor symptoms of PD. Articles pertaining to cognitive and mood dysfunction in PD, as well as treatment of sialorrhea with botulinum toxin, were previously reviewed as part of American Academy of Neurology practice parameters and were not included here. Methods: A literature search of MEDLINE, EMBASE, and Science Citation Index was performed to identify clinical trials in patients with nonmotor symptoms of PD published between 1966 and August 2008. Articles were classified according to a 4-tiered level of evidence scheme and recommendations were based on the level of evidence. Results and Recommendations: Sildenafil citrate (50 mg) may be considered to treat erectile dysfunction in patients with Parkinson disease (PD) (Level C). Macrogol (polyethylene glycol) may be considered to treat constipation in patients with PD (Level C). The use of levodopa/carbidopa probably decreases the frequency of spontaneous nighttime leg movements, and should be considered to treat periodic limb movements of sleep in patients with PD (Level B). There is insufficient evidence to support or refute specific treatments for urinary incontinence, orthostatic hypotension, and anxiety (Level U). Future research should include concerted and interdisciplinary efforts toward finding treatments for nonmotor symptoms of PD.
Affiliations:
- Canada, France, Royaume-Uni, États-Unis
- Angleterre, Floride, Grand Londres, Kansas, Ontario, Île-de-France
- Lawrence (Kansas), Londres, Paris, Tampa, Toronto
- Université de Floride du Sud, Université de Toronto, Université du Kansas
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000452
- to stream PascalFrancis, to step Curation: 000825
- to stream PascalFrancis, to step Checkpoint: 000317
- to stream Main, to step Merge: 001E07
- to stream Main, to step Curation: 001C86
- to stream Main, to step Exploration: 001C86
- to stream France, to step Extraction: 000192
Links to Exploration step
Pascal:10-0182479Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology</title><author><name sortKey="Zesiewicz, T A" sort="Zesiewicz, T A" uniqKey="Zesiewicz T" first="T. A." last="Zesiewicz">T. A. Zesiewicz</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of South Florida</s1><s2>Tampa</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Tampa</settlement><region type="state">Floride</region></placeName><orgName type="university">Université de Floride du Sud</orgName></affiliation></author><author><name sortKey="Sullivan, K L" sort="Sullivan, K L" uniqKey="Sullivan K" first="K. L." last="Sullivan">K. L. Sullivan</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of South Florida</s1><s2>Tampa</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Tampa</settlement><region type="state">Floride</region></placeName><orgName type="university">Université de Floride du Sud</orgName></affiliation></author><author><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I." last="Arnulf">I. Arnulf</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Paris 6 University</s1><s2>Paris</s2><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K. R." last="Chaudhuri">K. R. Chaudhuri</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>King's College Hospital</s1><s2>London</s2><s3>GBR</s3><sZ>4 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Morgan, J C" sort="Morgan, J C" uniqKey="Morgan J" first="J. C." last="Morgan">J. C. Morgan</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Medical College of Georgia</s1><s2>Augusta</s2><s3>USA</s3><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Medical College of Georgia</wicri:noRegion></affiliation></author><author><name sortKey="Gronseth, G S" sort="Gronseth, G S" uniqKey="Gronseth G" first="G. S." last="Gronseth">G. S. Gronseth</name><affiliation wicri:level="4"><inist:fA14 i1="05"><s1>University of Kansas</s1><s2>Kansas City</s2><s3>USA</s3><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Lawrence (Kansas)</settlement><region type="state">Kansas</region></placeName><orgName type="university">Université du Kansas</orgName></affiliation></author><author><name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J." last="Miyasaki">J. Miyasaki</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Toronto</s1><s3>CAN</s3><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Iverson, D J" sort="Iverson, D J" uniqKey="Iverson D" first="D. J." last="Iverson">D. J. Iverson</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Humboldt Neurological Medical Group, Inc</s1><s2>Eureka, CA</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Eureka, CA</wicri:noRegion></affiliation></author><author><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W. J." last="Weiner">W. J. Weiner</name><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Universiry of Maryland</s1><s2>College Park</s2><s3>USA</s3><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Universiry of Maryland</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">10-0182479</idno><date when="2010">2010</date><idno type="stanalyst">PASCAL 10-0182479 INIST</idno><idno type="RBID">Pascal:10-0182479</idno><idno type="wicri:Area/PascalFrancis/Corpus">000452</idno><idno type="wicri:Area/PascalFrancis/Curation">000825</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000317</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000317</idno><idno type="wicri:doubleKey">0028-3878:2010:Zesiewicz T:practice:parameter:treatment</idno><idno type="wicri:Area/Main/Merge">001E07</idno><idno type="wicri:Area/Main/Curation">001C86</idno><idno type="wicri:Area/Main/Exploration">001C86</idno><idno type="wicri:Area/France/Extraction">000192</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology</title><author><name sortKey="Zesiewicz, T A" sort="Zesiewicz, T A" uniqKey="Zesiewicz T" first="T. A." last="Zesiewicz">T. A. Zesiewicz</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of South Florida</s1><s2>Tampa</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Tampa</settlement><region type="state">Floride</region></placeName><orgName type="university">Université de Floride du Sud</orgName></affiliation></author><author><name sortKey="Sullivan, K L" sort="Sullivan, K L" uniqKey="Sullivan K" first="K. L." last="Sullivan">K. L. Sullivan</name><affiliation wicri:level="4"><inist:fA14 i1="01"><s1>University of South Florida</s1><s2>Tampa</s2><s3>USA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Tampa</settlement><region type="state">Floride</region></placeName><orgName type="university">Université de Floride du Sud</orgName></affiliation></author><author><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I." last="Arnulf">I. Arnulf</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Paris 6 University</s1><s2>Paris</s2><s3>FRA</s3><sZ>3 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K. R." last="Chaudhuri">K. R. Chaudhuri</name><affiliation wicri:level="3"><inist:fA14 i1="03"><s1>King's College Hospital</s1><s2>London</s2><s3>GBR</s3><sZ>4 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Morgan, J C" sort="Morgan, J C" uniqKey="Morgan J" first="J. C." last="Morgan">J. C. Morgan</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Medical College of Georgia</s1><s2>Augusta</s2><s3>USA</s3><sZ>5 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Medical College of Georgia</wicri:noRegion></affiliation></author><author><name sortKey="Gronseth, G S" sort="Gronseth, G S" uniqKey="Gronseth G" first="G. S." last="Gronseth">G. S. Gronseth</name><affiliation wicri:level="4"><inist:fA14 i1="05"><s1>University of Kansas</s1><s2>Kansas City</s2><s3>USA</s3><sZ>6 aut.</sZ></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Lawrence (Kansas)</settlement><region type="state">Kansas</region></placeName><orgName type="university">Université du Kansas</orgName></affiliation></author><author><name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J." last="Miyasaki">J. Miyasaki</name><affiliation wicri:level="4"><inist:fA14 i1="06"><s1>University of Toronto</s1><s3>CAN</s3><sZ>7 aut.</sZ></inist:fA14><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName><orgName type="university">Université de Toronto</orgName></affiliation></author><author><name sortKey="Iverson, D J" sort="Iverson, D J" uniqKey="Iverson D" first="D. J." last="Iverson">D. J. Iverson</name><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Humboldt Neurological Medical Group, Inc</s1><s2>Eureka, CA</s2><s3>USA</s3><sZ>8 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Eureka, CA</wicri:noRegion></affiliation></author><author><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W. J." last="Weiner">W. J. Weiner</name><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Universiry of Maryland</s1><s2>College Park</s2><s3>USA</s3><sZ>9 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Universiry of Maryland</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">Neurology</title><title level="j" type="abbreviated">Neurology</title><idno type="ISSN">0028-3878</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Neurology</title><title level="j" type="abbreviated">Neurology</title><idno type="ISSN">0028-3878</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>American</term><term>Nervous system diseases</term><term>Neurology</term><term>Parkinson disease</term><term>Treatment</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term><term>Pathologie du système nerveux</term><term>Traitement</term><term>Américain</term><term>Neurologie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Neurologie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objective: Nonmotor symptoms (sleep dysfunction, sensory symptoms, autonomic dysfunction, mood disorders, and cognitive abnormalities) in Parkinson disease (PD) are a major cause of morbidity, yet are often underrecognized. This evidence-based practice parameter evaluates treatment options for the nonmotor symptoms of PD. Articles pertaining to cognitive and mood dysfunction in PD, as well as treatment of sialorrhea with botulinum toxin, were previously reviewed as part of American Academy of Neurology practice parameters and were not included here. Methods: A literature search of MEDLINE, EMBASE, and Science Citation Index was performed to identify clinical trials in patients with nonmotor symptoms of PD published between 1966 and August 2008. Articles were classified according to a 4-tiered level of evidence scheme and recommendations were based on the level of evidence. Results and Recommendations: Sildenafil citrate (50 mg) may be considered to treat erectile dysfunction in patients with Parkinson disease (PD) (Level C). Macrogol (polyethylene glycol) may be considered to treat constipation in patients with PD (Level C). The use of levodopa/carbidopa probably decreases the frequency of spontaneous nighttime leg movements, and should be considered to treat periodic limb movements of sleep in patients with PD (Level B). There is insufficient evidence to support or refute specific treatments for urinary incontinence, orthostatic hypotension, and anxiety (Level U). Future research should include concerted and interdisciplinary efforts toward finding treatments for nonmotor symptoms of PD.</div></front></TEI><affiliations><list><country><li>Canada</li><li>France</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Floride</li><li>Grand Londres</li><li>Kansas</li><li>Ontario</li><li>Île-de-France</li></region><settlement><li>Lawrence (Kansas)</li><li>Londres</li><li>Paris</li><li>Tampa</li><li>Toronto</li></settlement><orgName><li>Université de Floride du Sud</li><li>Université de Toronto</li><li>Université du Kansas</li></orgName></list><tree><country name="États-Unis"><region name="Floride"><name sortKey="Zesiewicz, T A" sort="Zesiewicz, T A" uniqKey="Zesiewicz T" first="T. A." last="Zesiewicz">T. A. Zesiewicz</name></region><name sortKey="Gronseth, G S" sort="Gronseth, G S" uniqKey="Gronseth G" first="G. S." last="Gronseth">G. S. Gronseth</name><name sortKey="Iverson, D J" sort="Iverson, D J" uniqKey="Iverson D" first="D. J." last="Iverson">D. J. Iverson</name><name sortKey="Morgan, J C" sort="Morgan, J C" uniqKey="Morgan J" first="J. C." last="Morgan">J. C. Morgan</name><name sortKey="Sullivan, K L" sort="Sullivan, K L" uniqKey="Sullivan K" first="K. L." last="Sullivan">K. L. Sullivan</name><name sortKey="Weiner, W J" sort="Weiner, W J" uniqKey="Weiner W" first="W. J." last="Weiner">W. J. Weiner</name></country><country name="France"><region name="Île-de-France"><name sortKey="Arnulf, I" sort="Arnulf, I" uniqKey="Arnulf I" first="I." last="Arnulf">I. Arnulf</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K. R." last="Chaudhuri">K. R. Chaudhuri</name></region></country><country name="Canada"><region name="Ontario"><name sortKey="Miyasaki, J" sort="Miyasaki, J" uniqKey="Miyasaki J" first="J." last="Miyasaki">J. Miyasaki</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000192 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000192 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= Pascal:10-0182479
|texte= Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
}}
| This area was generated with Dilib version V0.6.29. |  |